Premium
Menorrhagia from a haematologist's point of view. Part II: management
Author(s) -
SIEGEL J. E.,
KOUIDES P. A.
Publication year - 2002
Publication title -
haemophilia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.213
H-Index - 92
eISSN - 1365-2516
pISSN - 1351-8216
DOI - 10.1046/j.1365-2516.2002.00621.x
Subject(s) - medicine , haemophilia , von willebrand disease , menarche , intensive care medicine , gynecology , levonorgestrel , von willebrand factor , pediatrics , family planning , population , environmental health , research methodology , platelet
The management of menorrhagia has until recently been the domain of the gynaecologist. As haematologists, we are now addressing the issue of optimal management of menorrhagia in our patients with bleeding disorders. Addressing three life periods, the menarche, reproductive years, and postchildbearing years, this review will discuss the use of oral contraceptive agents, antifibrinolytics, non‐steroidal anti‐inflammatory drugs, intranasal DDAVP and the new levonorgestrel‐impregnated IUD. Management of specific bleeding disorders will also be reviewed for von Willebrand disease, haemophilia A and B carriers, women with factor XI deficiency and PAI‐1 deficiency.